154 related articles for article (PubMed ID: 3135170)
1. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
Oizumi K; Hayashi I; Aonuma S; Konno K
Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.
Neu HC
Rev Infect Dis; 1982; 4 Suppl():S374-8. PubMed ID: 6294786
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.
Jones RN; Barry AL; Thornsberry C
Rev Infect Dis; 1982; 4 Suppl():S366-73. PubMed ID: 6294785
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction of cefotaxime and its metabolite desacetylcefotaxime demonstrated by drug-impregnated disks.
Stevens DL; Bergstrom R; Gibbons A
Diagn Microbiol Infect Dis; 1989; 12(1):73-80. PubMed ID: 2653715
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates.
Piédrola G; Galan I; Leyva A; Maroto MC
Drugs; 1988; 35 Suppl 2():62-4. PubMed ID: 3135171
[TBL] [Abstract][Full Text] [Related]
6. [In vitro synergy between cefotaxime and its main metabolite, desacetylcefotaxime].
Kobayashi S; Arai S; Hayashi S; Sakaguchi T; Kawana R
Jpn J Antibiot; 1988 May; 41(5):594-601. PubMed ID: 3216482
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity of cefotaxime and desacetylcefotaxime, alone or in combination, against gram-positive cocci.
Cruciani M; Navarra A; Di Perri G; Danzi MC; Concia E; Bassetti D
Drugs Exp Clin Res; 1990; 16(11):565-8. PubMed ID: 2101779
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of BMY-28142, a new cephalosporin.
Norden CW; Neiderriter K
Chemotherapy; 1987; 33(1):15-7. PubMed ID: 3103990
[TBL] [Abstract][Full Text] [Related]
9. The in-vitro activity of ceftazidime compared with that of other cephalosporins.
Bint AJ; Yeoman P; Kilburn P; Anderson R; Stansfield E
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():47-51. PubMed ID: 19802968
[TBL] [Abstract][Full Text] [Related]
10. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
Concia E; Marone P; Verani D; Marino P
Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
[TBL] [Abstract][Full Text] [Related]
11. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
Jones RN; Barry AL
Antimicrob Agents Chemother; 1987 May; 31(5):818-20. PubMed ID: 3606081
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial activity of ceftizoxime against gram-negative strains.
Debbia E; Soro O
Chemioterapia; 1985 Apr; 4(2):166-9. PubMed ID: 3891115
[TBL] [Abstract][Full Text] [Related]
14. An in vitro study of the interaction between cefotaxime and desacetylcefotaxime.
Winstanley TG; Spencer RC
Drugs Exp Clin Res; 1986; 12(12):967-71. PubMed ID: 3471432
[TBL] [Abstract][Full Text] [Related]
15. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test.
Reller LB
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219
[TBL] [Abstract][Full Text] [Related]
16. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
[TBL] [Abstract][Full Text] [Related]
17. In vitro antimicrobial activity of a novel aminothiazolylglycylcephalosporin, MT0703S, compared with that of ceftazidime, cefoperazone and aztreonam.
Okamoto R; Hara T; Yoshida T; Orikasa Y; Ogino H; Iwamatsu K; Inouye S
Drugs Exp Clin Res; 1990; 16(4):157-65. PubMed ID: 2127567
[TBL] [Abstract][Full Text] [Related]
18. The synergistic effect of cefotaxime and desacetylcefotaxime against clinical isolates of anaerobic bacteria.
Devlin HR; Boskovski L
Drugs; 1988; 35 Suppl 2():45-50. PubMed ID: 3396488
[TBL] [Abstract][Full Text] [Related]
19. Development of bacterial resistance to the third generation cephalosporins and their clinical use.
Kolár M; Látal T; Hájek V
J Chemother; 1999 Aug; 11(4):260-5. PubMed ID: 10465127
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity and beta-lactamase stability of cefodizime, a new cephalosporin antibiotic.
Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
Jpn J Antibiot; 1984 Jul; 37(7):1294-305. PubMed ID: 6092739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
